Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Multiple sclerosis.
Alterations of the human gut microbiome in multiple sclerosis.
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Successive pregnancies in multiple sclerosis.
Assessing response to interferon-β in a multicenter dataset of patients with MS.
A new dawn for genetic association studies in multiple sclerosis.
Women's experiences of menopause in an online MS cohort: A case series.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
Pages
« first
‹ previous
…
786
787
788
789
790
791
792
793
794
…
next ›
last »